Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_faa39c669d799fd78c788d419308c61c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4cdba0ff5061c10c00aa24d2dd6b9652 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fb04a4e1178b52613e473eb065001a01 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-18322 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-20022 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-165 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-115 |
filingDate |
2004-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_772bfdbd9ed51412bbe0d0d7c3ad80d9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c3ab67d568d8509ad55f4fb7f4c278a |
publicationDate |
2005-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2005007078-A2 |
titleOfInvention |
Method of inhibiting human metapneumovirus and human coronavirus in the prevention and treatment of severe acute respiratory syndrome (sars) |
abstract |
The present invention relates to peptides that show significant antiviral activity against viral respiratory disease. More particularly, the invention relates to the use of peptides to inhibit membrane fusion and infection by human metapneumovirus and/or human coronavirus in the prevention and treatment of Severe Acute Respiratory Syndrome (SARS) or other severe respiratory diseases caused by these agents. The peptides are derived from the known amino acid sequence of the fusion glycoproteins of each virus. |
priorityDate |
2003-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |